SEARCH RESULT

Total Matching Records found : 3852

USFDA scrutiny: Will pharma majors like Ranbaxy, Wockhardt be affected in long-term? -G Seetharaman

-The Economic Times Japanese companies do not mind erring on the side of caution. They are known to think longer and harder than their counterparts in other countries about big decisions, especially when it comes to entering a new market or acquiring a foreign company. But Japan's third biggest drugmaker Daiichi Sankyo would now wish it had spent more time doing due diligence on Ranbaxy Labs, in which it bought a...

More »

World listens to ‘Iron Lady of Jharkhand’ in the Big Apple -Narayan Lakshman

-The Hindu New York: Dayamani Barla was presented with the first ever Ellen L. Lutz Indigenous Rights Award by Cultural Survival, an indigenous peoples' rights organisation The Big Apple is renowned as the home of investment banks, glitzy fashion shows and other 21st-century tributes to prodigious wealth accumulation. But on Thursday it played host to a powerful symbol of Indian adivasis' struggle against oppression, Jharkhand activist and journalist Dayamani Barla. On a rainy...

More »

‘62% of Delhi-NCR households prefer organic food’ -Tuhin Dutta

-The Indian Express New Delhi: Around 62 per cent of high-income households prefer organic food due to rising awareness, higher disposable income and easy availability in the markets of big cities, a study by Assocham says. There has been a growth in the demand for organic products in metropolitan cities, especially fruits and vegetables, an increase of 95 per cent in the last five years. The survey titled "Rising demand of organic products...

More »

Ranbaxy's dark chapter-Bhupesh Bhandari

-The Business Standard Why have Indian authorities woken up to the Ranbaxy case only now? The matter had been simmering for several years The Ranbaxy affair is one of the darkest chapters of India's business history. The company has admitted it fudged data so that it could launch its products in the United States. It has now paid $500 million as a penalty to settle the case. It is worse than Ramalinga...

More »

New bulk drug export norms to comply with EU standards

-The Hindu The Commerce and industry Ministry, on Thursday, issued new guidelines for pharmaceutical makers to comply with the European Union (EU) Good Manufacturing Practice (GMP) standards. In a statement issued here, the Ministry says such a move will give a boost to pharma exports from India. "India has demonstrated its keenness to meet international requirements for exports of pharmaceutical products yet again by taking timely action for complying with the new...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close